Influence of discontinuation of medication after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension

Yaoita Nobuhiro (Sendai, Japan), Yaoita Nobuhiro, Sugimura Koichirou, Tatebe Shunsuke, Yamamoto Saori, Aoki Tatsuo, Miura Masanobu, Satoh Kimio, Shimokawa Hiroaki

Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Session: Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Session type: Poster Discussion
Number: 3601
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Yaoita Nobuhiro (Sendai, Japan), Yaoita Nobuhiro, Sugimura Koichirou, Tatebe Shunsuke, Yamamoto Saori, Aoki Tatsuo, Miura Masanobu, Satoh Kimio, Shimokawa Hiroaki. Influence of discontinuation of medication after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. Eur Respir J 2016; 48: Suppl. 60, 3601

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Balloon pulmonary angioplasty in a patient with chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2014; 23: 393-395
Year: 2014


Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
Source: International Congress 2019 – State of the art session: Pulmonary vascular diseases
Year: 2019


French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 53 (5) 1802095; 10.1183/13993003.02095-2018
Year: 2019



Effects of percutaneous transluminal pulmonary angioplasty on respiratory functions in patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots
Year: 2015


Effects of sildenafil as a bridge therapy for pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018


Antecubital venous access for balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016


Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2017; 26: 160111
Year: 2017



Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2009; 19: 64-67
Year: 2010



Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: the initial German experience
Source: Eur Respir J, 49 (6) 1602409; 10.1183/13993003.02409-2016
Year: 2017



Direct oral anticoagulant use and thrombus detection in patients with chronic thromboembolic pulmonary hypertension referred for pulmonary thromboendarterectomy
Source: International Congress 2019 – Chronic thromboembolic pulmonary hypertension
Year: 2019




Medical treatment in persistent pulmonary hypertension after pulmonary thrombendarterectomy in patients with chronic thrombembolic pulmonary hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 364s
Year: 2006

The assessment of lung function and residual hypoxemia after balloon pulmonary angioplasty for patients with non-operable chronic thromboembolic hypertension
Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Year: 2020


Multi-step therapy with riociguat, balloon pulmonary angioplasty, and cardiac rehabilitation for inoperable chronic thromboembolic pulmonary hypertension
Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Year: 2017


Balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension: is Europe behind?
Source: Eur Respir J, 53 (5) 1900843; 10.1183/13993003.00843-2019
Year: 2019



Balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension: is Europe behind?
Source: Eur Respir J, 54 (4) 1901639; 10.1183/13993003.01639-2019
Year: 2019



Pulmonary angioplasty vs exclusive medical treatment in inoperable chronic thromboembolic hypertension–initial outcomes from a pulmonary hypertension centre
Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Year: 2020


Adherence to disease-specific drug treatment among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
Source: ERJ Open Res, 6 (4) 00299-2020; 10.1183/23120541.00299-2020
Year: 2020



Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension (CTEPH): does it perform as well as we hoped?
Source: International Congress 2018 – New trends in the management of pulmonary hypertension
Year: 2018


Acute haemodynamic effects of adaptive servoventilation therapy in patients with pulmonary arterial hypertension and patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015

Persistent exercise intolerance after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 55 (6) 2000109; 10.1183/13993003.00109-2020
Year: 2020